GlassScriptPhysician profile
Paul N Maton
NPI 1538143466
$2,584.13
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $156 · 2021: $301 · 2022: $230 · 2023: $138 · 2024: $1,534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500 · Food and Beverage: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
| Food and Beverage | $171.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $1,510.80 | 2024 | Voquezna |
| Abbvie INC. | $413.13 | 2019-2024 | |
| Janssen Biotech, INC. | $166.76 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $107.24 | 2019-2023 | Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $85.72 | 2021-2023 | Gattex |
| Daiichi Sankyo INC. | $70.99 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $37.76 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $35.02 | 2023 | Dupixent |
| Amgen INC. | $27.39 | 2021-2023 | Avsola, Amjevita |
| Ironwood Pharmaceuticals, INC | $25.03 | 2021-2022 | |
| Gilead Sciences, INC. | $24.52 | 2019-2022 | |
| Ardelyx, INC. | $19.14 | 2022 | |
| Pharmacosmos Therapeutics INC. | $18.34 | 2023 | Monoferric |
| Shire North American Group INC | $15.97 | 2019 | |
| Qol Medical, LLC | $14.31 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $12.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Maton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.